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Abstract
Objectives The aim of this study is to evaluate secondary intention healing process and postoperative pain of oral soft tissues after
laser surgery with the use of a compound containing chlorhexidine and sodium hyaluronate.
Materials and methods This double-blind, randomized clinical study included 56 patients affected by benign oral lesions and
subjected to excisional biopsy with diode laser and randomly divided into three groups. Study group (SG) received 0.2%
chlorhexidine digluconate and 0.2% sodium hyaluronate treatment; control group (CG) received 0.2% chlorhexidine
digluconate; and placebo group (PG) followed the same protocol, taking a neutral solution having the same organoleptic
characteristics. Wound healing was evaluated using percentage healing index (PHI). Numeric rating scale (NRS) was used to
evaluate postoperative pain.
Results PHI (T1 = 7 days) was 67.25% for SG, 58.67% for CG, and 54.55% for PG. PHI (T2 = 14 days) was 94.35% for SG,
77.79% for CG, and 78.98% for PG. A statistically significant difference was between the groups for PHI at T2 p = 0.001. No
difference was detectable for pain index.
Conclusions A solution containing sodium hyaluronate and chlorhexidine is a good support to increase wound healing by
secondary intention after laser biopsy, but no differences were in postoperative perception of pain.
Clinical relevance The use of the tested solution can be recommended after laser oral biopsies, to achieve a healing without
suture. About the postoperative pain, the compound has not showed the same results and did not have measurable effects.
Keywords Sodium hyaluronate .Wound healing . Postoperative pain . Laser . Oral biopsy . Chlorhexidine digluconate
Introduction
Oral biopsy is a standard procedure for the diagnosis of oral
mucosa lesions. It is a surgical treatment that can provoke
secondary effects like pain and inflammation, depending on
the degree of the tissue damage produced [1].
Thanks to its features, laser is often used to perform oral
biopsies. In fact, it carries out several advantages to daily
surgical procedures for the operator and patient,
comprehending a partial decontamination of the surgical field,
less bleeding, thanks to the laser-hemoglobin interaction, with
greater visibility and the possibility to execute surgery in
* Gaspare Palaia
gaspare.palaia@uniroma1.it
Gianluca Tenore
gianluca.tenore@uniroma1.it
Luca Tribolati
luca.tribolati@gmail.com
Claudia Russo
claudia.russo@uniroma1.it
Gianfranco Gaimari
gianfranco.gaimari@uniroma1.it
Alessandro Del Vecchio
alessandro.delvecchio@uniroma1.it
Umberto Romeo
umberto.romeo@uniroma1.it
1 Department of Oral and Maxillo-Facial Sciences, BSapienza^
University of Rome, via Caserta 6, 00162 Rome, Italy
Clinical Oral Investigations
https://doi.org/10.1007/s00784-018-2735-0
patients with coagulation disorders, in particular using the
diode laser [2–4]. Furthermore, it consents to have less post-
operative pain, inflammation, and as one of the best benefits,
wound healing by secondary intention thanks to the coagula-
tion capacity [5–7]. Oral biopsy performed by laser permits to
not use suture that can delay healing by plaque increasing [8].
Healing by primary intention provides a mechanism with
deposition of proteoglycans, collagen, and proteins to form a
connective extracellular matrix instead of healing by second-
ary intention permits a heal by contraction, with tissue move-
ment from the margin to the center of wound. This healing is
based on a complex mechanism between contractile fibroblast
and extracellular matrix [9]. Awound generally heals into four
phases, characterized by specific markers and condition
comprehending, hemostasis, inflammation, proliferation, and
remodeling phases. The healing starts at the moment of an
injury with hemostasis, where the platelets release clotting
factors, growth factors, and cytokines. In the next phase, neu-
trophils begin the phagocytosis and remove bacteria, damaged
tissue, and foreign materials with the aid of macrophages.
Afterwards, fibroblasts migrate and deposit new extracellular
matrix recovering structure and function to the tissue, a char-
acteristic of proliferative phase. During this phase, the pre-
dominant cell is fibroblast that produces collagen and glycos-
aminoglycans like ialuronic acid. The last phase is the remod-
eling one, where collagen matrix begins to be organized [10].
Hyaluronic acid (HA) is a molecule introduced to promote
wound healing [11], found in many tissues [12]. It has got
numerous properties bringing advantages for wound healing
such as granulation tissue formation, inhibition of destructive
inflammation, and promotion of angiogenesis and
reepithelization [11, 13]. HA is used in numerous medical
disciplines; it is devoid of toxicity and for topical oral use is
available in gel or liquid preparation [12, 14].
In literature, it has been shown that wound healing can be
facilitated and accelerated by the application of sodium
hyaluronate stimulating fibroblasts, increasing the production
of growth factors and the biosynthesis of different types of
collagen [15].
Romeo et al. [16] evaluated in a randomized clinical study,
the healing of soft tissue after laser surgery, with or without the
use of a gel based on amino acids and sodium hyaluronate.
Patients have been divided into a study group, where amino
acid and sodium hyaluronate-based gel was administered and
in a control group, in which no substance was applied on the
wound. The results showed a rate of better healing and more
rapid tissue repair of the wounds in the study group.
Another study conducted byMariggio’ et al. [15] evaluated
the effects induced by the high molecular weight of HA and a
pool of amino acids on the proliferation of human fibroblasts
and deposition of collagen I and III. It has been also studied
the action on the production of growth factors involved in
angiogenesis, deposition of extracellular matrix proteins and
expression of pro-inflammatory cytokines fundamental for the
recall of macrophages, and proliferation of keratinocytes.
In many cases, post-operative instructions after oral biopsy
involving the use of chlorhexidine have been considered a
good prophylactic against postoperative infection, also due
to the fact that patients cannot maintain good oral hygiene
[17–19].
In virtue of this, the application of CURASEPT®ADS020
TRATTAMENTO RIGENERANTE (CURADEN
HEALTHCARE), a solution composed of chlorhexidine
digluconate 0.2% and sodium hyaluronate 0.2%, has been
recommended to treat the symptoms and the wound healing
of oral laser biopsy lesions with different etiologies.
Biopsy is necessary to obtain a definitive diagnosis of oral
lesions, so it is important to reduce postoperative pain, de-
crease the healing time, and have a clear understanding of
post-operative course associated to this procedure and to bet-
ter support patients during the postoperative course.
The aim of the present study was to evaluate the efficacy of
rinses with a solution of sodium hyaluronate and chlorhexi-
dine digluconate, in improving laser wound healing and pain
experienced by patients after oral mucosa biopsy, comparing it
with the use of only chlorhexidine or placebo solution.
Material and methods
This randomized double-blind clinical study was performed at
the Complex Operative Unit of Stomatology of the
Department of Oral and Maxillo-Facial Sciences,
BSapienza^ University of Rome, Italy, from October 2014 to
May 2017. According to the Declaration of Helsinki (2008),
all patients participating at the study were properly informed
about its features, and before starting the clinical section, they
had to read and sign a written informed consent. Moreover,
the study protocol was approved by the Ethics Committee of
the BSapienza^ University of Rome (protocol reference: CE
4011).
The inclusion criteria consisted in the presence of a benign
lesion (Fig. 1), like fibromas, mucoceles, and HPV lesions, in
different areas of the oral cavity, such as the buccal mucosa,
tongue, and lips, requiring histopathologic analysis for diag-
nostic purposes. Patients affected by systemic diseases, prob-
lems of hemostasis, and coagulation, with poor oral hygiene
and with an allergy or hypersensitivity to the used products,
were excluded from the study.
To determine the sample size, a power of 80% was consid-
ered, with beta-value of 0.20, a confidence level of 95% and a
confidence interval of 5. A sample size calculator made by
Creative Research Systems was used and indicated 47 patients
to validate the study.
Before each intervention, patients were randomly allocated
from a computer-generated list of random numbers into one of
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three groups (Study Group or SG, Control Group or CG,
Placebo Group or PG) (Fig. 2).
Allocation concealment was achieved through the provi-
sion, by professionals not involved in patient enrollment, of
a numbered sequence of opaque and sealed envelopes con-
taining the assignment code. The list remained inaccessible,
and the envelopes were opened, sequentially, after enrolling
the patient and obtaining consent.
Oral biopsies have been performed using a diode laser
(980 nm, 2.5 W in CW, fluence 1990 J/cm2, with a fiber
diameter of 400 μm, LEONARDO®, DMT s.r.l.—20851
Lissone (MB)—Italy) by the same operator in order to mini-
mize differences due to operator variability. Local anesthesia,
with 1.8 mL of mepivacaine solution (MEPIVACAINA
PIERREL®, 30 mg/ml, injection solution 1.8 ml, Pierrel
Spa, Milan, Italy), was administered before the beginning of
each surgical intervention, and after surgery, all samples have
been sent to the pathologist for histological evaluation and
diagnosis.
No sutures have been applied to obtain wound healing by
secondary intention (Fig. 3).
After biopsy:
& SG had to make a rinse with one plug of 0.2% chlorhex-
idine digluconate and 0.2% sodium hyaluronate
( CURASEPT® ADS 0 2 0 TRATTAMENTO
RIGENERANTE), for 1 min, immediately after surgery
and two times daily for 2 weeks, after routine meals and
after regular oral care procedures at home.
& CG had to follow the same protocol as SG, but using 0.2%
chlorhexidine digluconate (CURASEPT® ADS020).
& PG following the same protocol as SG and CG received a
neut ra l solu t ion , pred isposed by CURADEN
HEALTHCARE, having the same organoleptic
characteristics.
The mouthwashes were provided to the patient by our unit.
Each of them had an X, Y, and Z code according to the com-
pound used. X represented the SG, Y the CG, and Z the PG.
The patient and the operator were unaware of the contents
of the mouthwash (double-blind study).
Furthermore, instructions have been given to patients in
order to not take any liquid or solid foods and to abstain from
rinsing their mouths for at least 30 min after the application of
the compound to obtain a good distribution and absorption.
No other medications (such as antibiotics or FANS) have been
prescribed thanks to laser advantage in decreasing postopera-
tive pain [2, 3].Wound healing evaluation has been performed
using digital photographic controls taken immediately after
surgery (T0), 7 days after surgery (T1), and 14 days after
surgery (T2). Pictures have been taken with a digital camera
(NIKON D200®, Nikon Corporation, Tokyo, Japan) through
the use of an L-shaped graph paper benchmark (with 1-mm
intervals) (Fig. 4), put on the sides of the treated area. The
obtained high-resolution pictures were edited using graphics
software (ADOBE PHOTOSHOP CC®, Adobe Systems, San
Jose, CA). After having delimited the lesion edges and set
1 mm value with benchmark, the area has been calculated in
square millimeters (Fig. 5) to obtain three different values: the
Fig. 2 Various mouthwashes that can be assigned through randomization Fig. 3 Removal of the lesion by the laser and the residual injury
Fig. 1 Benign oral lesions, which histological examination was found to
be focal fibrous hyperplasia
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wound area at T0, the wound area at T1, and the wound area at
T2. The resulting values have been examined to calculate a
percentage value, called percentage healing index (PHI) at T1
and T2. First, the T1 area was divided by the T0 area before it
was multiplied by 100, and then, the same procedure with T2
divided by T0. The obtained value, also called percentage
unhealed index (PUI), represented the percentage of the lesion
that did not heal over a 7-day period or 14-day period. The
complementary value to this percentage was defined as the
PHI at T1 and PHI at T2 (e.g., PUI = T1/T0 · 100 =
16.6 mm2/50.2 mm2 · 100 = 33.06%; PHI = 100–PUI = 100–
33.06 = 66.94%).
Numeric rating scale (NRS) was used to evaluate the se-
verity of pain. This NRS consisted in a 100-mm horizontal
line, using a 10-point, anchored at one end with the words Bno
pain^ or value 0 and at the other end with the words Bworst
pain imaginable^ or value 10, with intermediate values from 1
to 9. Each patient was instructed how to use the scale and
asked to mark the intensity of pain at 2, 4, 6, 8, 12, and 24 h
after biopsy, and daily for the next 6 days. The measurements
were recorded by patients at home always at 12:00 p.m. and
after 7 days from biopsy they have been visited (Fig. 6).
After this clinical section, patients’ age and gender, biopsy
site, PHI at T1, PHI at T2, and pain felt have been collected
and statistically analyzed.
Statistical analysis
Data were statistically described in terms of mean, standard
deviation (SD), median and range, or frequencies (number of
cases) and percentages when appropriate. For comparing cat-
egorical data, chi-square test was performed. Comparison of
PI between the groups for any interval time and comparison of
PHI between the groups was done using Kruskall-Wallis test
with multiple post hoc two-group comparisons. Exact test was
used instead when the expected frequency is less than 5. p-
values less than 0.05 were considered statistically significant.
All statistical calculations were done using computer program
GraphPad 7 (GraphPad Software, La Jolla, CA) for Mac Os.
Results
A total of 56 patients, 37 female and 19 male, were included,
with a drop out of 16% for a total of 47 patients.
All the data about sex, age, and biopsy site in every group
are reported in Table 1.
The study resulted to be properly randomized.
The statistical analysis showed a p value of 0.844 for gen-
der and a p value of 0.611 for anatomical area, while for age
test showed a p value of 0.137, with no statistically significant
difference between three groups.
The test for the wound areas in the three groups showed
that there was no statistically significant difference (p = 0.427)
between the average wound area at T0 in all of them.
The mean area value was also calculated, resulting
50.92 mm2 in SG (SD = 41.1) with a range of 6.52 to 154.9,
for CG was 60.98 mm2 (SD = 38.41) with range of 5.91 to
129.5, while in PG was 42.44 mm2 (SD = 22.08) (Figs. 7 and
8). The CONSORT flowchart of the study is reported in Fig. 9.
PHI values at T1 of SG, CG, and PG are reported in
Table 2. The difference between SG and CGwas 8.58%,while
a difference of 12.7% between SG and PG was observed.
Testing the difference between the three groups with
Kruskall-Wallis test revealed a nonsignificant difference
(p = 0.260) for PHI at T1. The multiple comparison test shows
a nonsignificant difference.
PHI values at T2 of SG, CG, and PG are reported in Table 2
too. A difference of 16.56% between SG and CG and a dif-
ference of 15.37% between SG and PG was observed.
The Kruskall-Wallis test revealed a significant difference
(p = 0.001) for PHI at T2 between three groups. The multiple
comparison test of SG with CG shows a significant difference
(p = 0.010), same thing for SG with PG (p = 0.002), while the
Fig. 4 Wound area with an L-shaped graph paper benchmark (with 1-mm
intervals)
Fig. 5 Use of graphics software (ADOBE PHOTOSHOP CC®, Adobe
Systems). After having delimited the lesion edges and set 1 mm value
with benchmark, the area has been calculated in square millimeters
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comparison of CG with PG shows a nonsignificant difference
(p > 0.999).
Fifty patients on 56 completed the analysis of pain. In fact,
six of them did not compile the evaluation form or did not
return for the control. The evaluation forms showed lower
values in the first 2 h, while the maximum peak appeared at
the fourth hour in all groups; this was probably due to the fact
that in the first 2 h, there still remains the effect of anesthesia.
The maximal pain value was recorded by the study group, at
4 h after biopsy, interval time considered the maximum peak
in all groups, with a mean value of 2.1 (SD = 2.2, 95%CI
between 1.01 and 3.19) with range 0 to 6; in CG was 1.3
(SD = 1.6, 95%CI between 0.41 and 2.19) with range 0 to 5
while in PG was 1.8 (SD = 2.2, 95%CI between 0.53 and
3.07) with range 0 to 7, and then the value gradually decreased
in all three groups (Table 3).
In SG from a mean value of 2.1 (0–6) at the maximum
peak, it descended to a mean value of 0.4 seven days after
biopsy with a range from 0 to 3, showing a reduction of 1.7
point. The maximum reduction between time point was
shown from 8 to 12 h with 0.4 point. Furthermore, in CG from
a mean value of 1.3 (0–5) at the maximum peak, the mean
value descended to 0.2 at day 7 with range 0 to 2, showing a
total reduction of 1.1 point.
The maximum reduction between time point was shown
from 6 to 8 h with 0.4 point. Moreover, in PG, the mean value
at maximum peak was 1.8 (0–7), and the mean value at day 7
was 0.2 (0–2) with a total reduction of 1.6 point. The
Fig. 6 Numeric rating scale with
time interval
Table 1 Patients characteristics,
with age, gender, and anatomical
area of the lesions. SD standard
deviation, SH sodium
hyaluronate, CHX chlorhexidine
digluconate. Data in parentheses
are percentages
Characteristic X group (study group) Y group 4 (control group) Z group (placebo group)
SH + CHX (n = 20) CHX (n = 18) Neutral (n = 18)
Age (year)
Mean 46.05; SD = 18.56 56.8; SD = 15.49 54.2; SD = 17.29
Range 14–75 21–78 17–81
Gender (n)
Male (19) 6 (31.6%) 7 (36.8%) 6 (31.6%)
Female (37) 14 (37.8%) 11 (29.7%) 12 (32.5%)
Site (n)
Lip (14) 6 (42.8%) 4 (28.6%) 4 (28.6%)
Cheek Mucosa (17) 6 (35.3%) 5 (29.4%) 6 (35.3%)
Gums (13) 0 1 (33.3%) 2 (66.7%)
Palate (4) 1 (33.3%) 3 (66.7%) 0
Tongue (17) 6 (35.3%) 5 (29.4%) 6 (35.3%)
Mouth floor 1 (100%) 0 0
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maximum reduction of 0.4 point between time point was
shown from 12 to 24 h.
Finally, statistical analysis did not find a significant differ-
ence in any time interval between the three considered groups.
Discussions
This randomized double-blind clinical study, was performed
to evaluate the efficacy of a solution composed by sodium
hyaluronate and chlorhexidine digluconate comparing it with
a chlorhexidine digluconate solution and a placebo solution in
secondary intention healing process and postoperative suf-
fered pain, after excisional biopsy of the oral mucosa.
A three-group RCT was planned instead of a two-group
because of the evaluation of the efficacy of chlorhexidine
alone or in combination with sodium hyaluronate. A placebo
group was fundamental especially to evaluate pain perception.
The management of post-surgical wounds aims to
wound healing as soon as possible, obtaining a smooth
surface, without scars or retracting injury and minimizing
pain and discomfort for the patient. An improvement of
repair process and reduction of pain may increase the
postoperative comfort of the patients. Tissue repair can
be adversely affected by many factors such as infections,
hypoxia, metabolic disorders such as diabetes mellitus,
and presence of necrotic tissue [20].
The presence of a greater or lesser amount of hyaluronic
acid affects the clinical response of healing processes. That is
to say, the difference in the response depends on the levels and
the concentrations of hyaluronic acid [21].
From these clinical evidence, it is clear that, during the
healing of tissues, to have hyaluronic acid gives the fabric a
constant supply of a risk factor for the reconstitution of the
original tissue architecture [22].
Due to the role that hyaluronic acid have in faster resolution
of post-surgical wound, a solution with chlorhexidine
digluconate and sodium hyaluronate has been recently and
systematically used with clear protocols in order to check
the real benefits that it can lead both about the timing of the
pathology resolution and the correct and less traumatic as
possible post-operative course. The used compound contains
purified water, xylitol, propylene glycol, Peg-40 hydrogenat-
ed castor oil, ascorbic acid, chlorhexidine digluconate, sodium
hyaluronate, aroma, poloxamer 407, sodium metabisulfite,
sodium citrate, and citric acid.
According to wound healing, it has been shown that after
7 days from laser surgery, in the SG, the average percentage of
healing was higher than compared to the CG, treated only with
chlorhexidine, and PG treated with a neutral solution, with
nonsignificant difference between the groups. Moreover, after
14 days, the results showed even more marked differences
between the SG and the remaining two groups and a healing
rates close to 100%, with a statistically significant difference
(p = 0.001).
The effect of the compound, especially for the presence of
sodium hyaluronate, seems to show a greater efficacy in the
late stage of the wound healing, probably due to the fact that
the fibroblasts and their products are involved in the third
phase of wound healing, defined proliferation. Therefore, in
the study group, where patients have been subjected to the
administration of the compound with sodium hyaluronate
and chlorhexidine, there was a more rapid healing of the sur-
gical wound, thanks to its chemical-physical and biological
characteristics in promoting the process wounds repair, in
terms of fibroblast proliferation, granulation tissue formation,
deposition of collagen, and stimulation of the production ofFig. 8 a, b The graph is mean with range (p = 0.260 and p = 0.001)
Fig. 7 The graph is mean with range (p = 0.427)
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growth factors involved in the deposition of the extracellular
matrix and in the vasculature.
The results obtained in this study are generally in line with
those described in the literature, where sodium hyaluronate
action has been well shown.
Colella et al. [23, 24] have studied and analyzed the
mechanisms involved in wound healing and the molecular
changes induced in keratinocytes and fibroblasts through
the use of sodium hyaluronate alone or in combination
with synthetic amino acids, concluding that the HA is able
to induce changes in expression of genes related to the
migratory phenotype of the keratinocytes and promote the
activity of fibroblasts by promoting re-epithelialization
and wound closure. As reported by other studies [25],
the application of gel with sodium hyaluronate and amino
acids in wound healing of soft tissue and hard tissue after
tooth extraction showed a higher average percentage of
healing with regard to both soft and hard tissue.
In this study, the wound area treated only with chlorhexi-
dine (CG) showed a higher PHI than the PG at T1, while at T2
(14 days) showed an average of percentage healing index
lower than PGwith nonsignificant difference in multiple com-
parison test. This is probably due to the effect of chlorhexidine
both on bacterial load in the early stage of wound healing,
CONSORT FLOWCHART
Assessed for eligibility
(n = 66)
Excluded (n = 10)
Not meeng inclusion criteria
(n = 7)
Refused to parcipate
(n = 3)
Randomized (n = 56)
Allocated to 
Study Group 
(n = 20)
 Received allocated 
intervention (n=20 )A
ll
o
ca
ti
o
n
E
n
ro
ll
m
en
t
Allocated to 
Control Group 
(n = 18)
 Received allocated 
intervention (n= 18 )
Fo
llo
w
 u
p
Lost to follow up:
n=2
Paents did not come to 
the scheduled controls
Lost to follow up:
n=3
Paents did not come to 
the scheduled controls
A
n
a
ly
si
s Analyzed (n = 18)
Excluded from analysis
(n =0) 
Analyzed (n = 15)
Excluded from analysis
(n =0) 
Allocated to 
Placebo Group 
(n = 18)
 Received allocated 
intervention (n=18 )
Lost to follow up:
n=4
Paents did not come to 
the scheduled controls
Analyzed (n = 14)
Excluded from analysis
(n =0) 
Fig. 9 CONSORT flowchart
Clin Oral Invest
particularly in inflammatory phase, and on fibroblasts more
present in a late stage, particularly in the proliferation phase.
n fact, the use of chlorhexidine during wound healing is
based on the concept that it is able to reduce the bacterial load
of the wound area. The role of bacteria in delaying wound
healing has been established [26]. Wound infection interferes
with the normal wound healing process [27, 28]; conversely, a
low bacterial load can positively influence wound healing,
accentuating the inflammatory reaction, essential for tissue
healing [29].
In addition to this, there are several studies about the use and
the capability of chlorhexidine showing important contradiction
on its effect on wound healing. Different in vitro studies showed
that chlorhexidine negatively affected fibroblast and
keratinocyte proliferation in a degree concentration and time
dependent [30–33]. On the other side, only few in vivo studies
showed a negative effect of chlorhexidine [34, 35]. This contra-
diction can be explained because of the different cellular and
molecular interactions happening in vitro and in vivo.
In particular, in the oral cavity, the chlorhexidine primarily
binds to bacteria and an additional amount of applied chlor-
hexidine is precipitated by proteins [36, 37]. Therefore, the
remaining chlorhexidine, addressed to bind cells in the wound
area, is reduced [38].
Kozlovsky et al. [38] found that chlorhexidine enhanced
wound healing significantly at the histological level but not at
the clinical level. Another study on wound healing in rats re-
vealed that wound healing was disturbed by a 0.5% chlorhexi-
dine and delayed with a concentration of 0.1% and 0.2% [34].
In order to measure wound healing, the traditional digital
photograph assessment was performed. Nowadays, this is the
most used method, although other techniques using laser-
assisted wound measurement (LAWM) device were reported
in literature [39].
Furthermore, considering the pain as a subjective feeling,
the response to painful stimoli depends on personal, cultural,
and social factors [40]. This study uses a subjective evaluation
of postoperative pain, reported by the patient through a NRS, a
simple method of self-rating subjective sensations that is con-
sidered a valid method of pain evaluation [41, 42].
A pilot study from Vescovi et al. [43] showed that a com-
pound of amino acids and sodium hyaluronate gel based
promotes not only an improvement in the healing process
but also a lower and thus better perception of pain in the
immediate postoperative period. These authors performed bi-
opsies of benign oral lesions with the laser, subdividing pa-
tients into two groups. A better algic response was shown in
patients to whom was administered and recommended the
application of a basis of amino acids and sodium hyaluronate
gel.
In our study results, the perceived pain considerably varies.
In fact, the use of the compound showed a similar pain reduc-
tion into the three groups. However, the values do not appear
to be statistically significant among these.
Therefore, the evaluation of postoperative pain perception
tends to differ, depending not only on the used compound but
also on the individual perception, on the location of the lesion
in the oral cavity and on the size of the lesion, which can have
a big impact on the perception.
The limitations of our study mainly concern the number of
samples and the comparison of wound healing in various oral
anatomical areas. Each site of the oral cavity may have differ-
ent healing times, depending on the type of epithelium and the
type of function, so large numbers are required to make a
definitive assessment.
Conclusions
The results of the study showed that the application of a solu-
tion with a compound of sodium hyaluronate and chlorhexi-
dine digluconate on surgical wounds after oral mucosa laser
biopsy can significantly improve the healing process and then
wound healing. So, the use of this compound can be recom-
mended in all cases where laser surgical procedures are need-
ed, in order to better achieve a healing by secondary intention.
Therefore, even if the followed protocol showed the effective-
ness and validity of the product with excellent properties in
tissue repair, more cases are needed to better minutely inves-
tigate its action.
Funding This research has been financially supported by CURADEN
HEALTHCARE. The protocol and data presented have been carried out
by the authors.
Table 2 PHI values at T1 and T2
Group PHI (T1) PHI (T2)
SG 67.25% (SD = 26.94, 95%CI between 56.25 and 80.65)
with a range from 9.84 to 100%
94.35% (SD= 10.18, 95%CI between 89.29 and 91.41)
with a range from 61.09 to 100%
CG 58.67% (SD = 21.7, 95%CI between 46.63 and 70.67)
with a range from 7.14 to 84.24%
PHI at T2 of 77.79% (SD= 22.55, 95%CI
between 65.30 and 90.28) with a range from 18.88 to 100%
PG PG showed an average PHI at T1 of 54.55% (SD = 24.18, 95%CI
between 40.59 and 68.51) with a range from 8.63 to 85.46%
78.98% (SD= 15.5, 95%CI between 70.03 and 87.93)
with range from 39.48 to 100%
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